Impact:Improving Adherence and Commitment to Treatment
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Type 2 Diabetes
- Sponsor
- Clalit Health Services
- Enrollment
- 500
- Locations
- 1
- Primary Endpoint
- Diabetes Control as Expressed by the Change in HbA1c %
- Last Updated
- 8 years ago
Overview
Brief Summary
In the IMPACT project, the investigators want to improve adherence and commitment to treatment.
Detailed Description
In this study the investigators use 3 interventions in diabetic patients and one control, to find what is the best intervention to improve adherence to healthy life style and medication therapy. the 3 intervention as followed: 1) meetings and follow-up by the medical team; 2) meetings and follow-up by trained peers; 3) system for sending SMS, operate according to algorithm.
Investigators
Eligibility Criteria
Inclusion Criteria
- •type 2 diabetes
- •Oral medication or insulin
- •According to the HbA1c test result, 0.5% above the target for the patient's personal balance and below the 10%, the most recent, but in any event not more than six months prior to the study patient recruitment
- •Patients speak and read Hebrew
- •owners of a mobile phone that can receive text messages (SMS messages/ notifications) and have the ability to use the application (relevant for the SMS notification arm)
Exclusion Criteria
- •Active malignant disease
- •creatinine levels above 2
- •Getting medicines that elevate sugar levels as steroids, chemotherapy
- •Three months after Myocardial Infraction (myocardial ischemia), surgical intervention, cardiac event
- •Patients who are planning major surgery
- •Patients who are planning a residential zone change
- •Patients with acute complications of diabetes under active treatment (such as limb amputation)
- •Patients diagnosed with unbalanced mental disorders
- •patients who can not sign the form on their own "informed consent"
- •patients suffering from dementia
Outcomes
Primary Outcomes
Diabetes Control as Expressed by the Change in HbA1c %
Time Frame: 0, 6, 12 & 18 months
Participants will undergo HbA1c periodical lab test, the data needed for the trial will be extracted from electronic medical record